You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Nonpharmacologic and Digital Therapeutics: Psychiatry Updates

  • Authors: Hansa Bhargava, MD; Sanjay Gupta, MD; Geraldine Dawson, PhD; Mark S. George, MD; Scott H. Kollins, PhD; Rajnish ("Raj") Mago, MD; John Torous, MD, MBI; 
  • CME / CE Released: 12/27/2021
  • Valid for credit through: 12/27/2022
Start Activity

  • Credits Available

    Physicians - maximum of 2.00 AMA PRA Category 1 Credit(s)™

    Nurses - 2.00 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for psychiatrists, primary care physicians (PCPs), pediatricians, nurse practitioners (NPs), and physician assistants (PAs) involved in the care of patients with psychiatric conditions.

The goal of this activity is to improve the learners' knowledge regarding the use of therapeutic brain modulation, digital solutions, technologies, and pharmacogenetics in psychiatry.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical data for the use of neuromodulatory devices for the management of psychiatric disorders
    • The role of digital tools for the recognition of psychiatric disorders
    • The role of digital therapeutics in psychiatric disorders
    • Clinical data on pharmacogenomic considerations for the management of psychiatric disorders
    • Technologies available to help patients access care


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Co-Chairs

  • Hansa Bhargava, MD

    Senior Medical Director at WebMD and Medscape
    American Academy of Pediatrics Children's Healthcare of Atlanta
    Emory University
    University of Toronto Faculty of Medicine
    Atlanta, Georgia
     

    The opinions expressed are those of Dr Bhargava and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Bhargava’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.

    Disclosures

    Disclosure: Hansa Bhargava, MD, has disclosed no relevant financial relationships

  • Sanjay Gupta, MD

    Consulting Psychiatrist
    Dent Neurological Institute
    Buffalo/Niagara, New York

    Disclosures

    Disclosure: Sanjay Gupta, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Intracellular Therapies
    Served as a speaker or a member of a speakers bureau for: AbbVie, Inc.; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Intracellular Therapies; Janssen Pharmaceuticals; Neurocrine Biosciences, Inc.; Otsuka Pharmaceutical Company, Inc.; Sunovion Pharmaceuticals, Inc.

Faculty

  • Geraldine Dawson, PhD

    William Cleland Distinguished Professor
    Department of Psychiatry and Behavioral Sciences
    Director
    Duke Center for Autism and Brain Development
    Duke University School of Medicine
    Durham, North Carolina

    Disclosures

    Disclosure: Geraldine Dawson, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Akili Interactive Labs, Inc.; Apple Inc.; Gerson Lehrman Group; Guidepoint Global, Inc.; Janssen Research and Development; LabCorp, Inc.; Roche Pharmaceutical Company; Tris Pharma, Inc.
    Served as a speaker or a member of a speakers bureau for: Tris Pharma, Inc.
    Owns stock, stock options, or bonds from: Neuvana, Inc.
    Other: Dr. Dawson has the following patent No. 10,912,801 and patent applications: 62,757,234, 25,628,402, and 62,757,226. Dr Dawson has developed technology, data, and/or products that have been licensed to Apple, Inc. and Cryocell, Inc. and Dr. Dawson and Duke University have benefited financially.

  • Mark S. George, MD

    Layton McCurdy Endowed Chair​
    Distinguished Professor of Psychiatry, Radiology, and Neuroscience​
    Director, Brain Stimulation Division, Psychiatry​
    Medical University of South Carolina​
    Charleston, South Carolina​
    Staff Psychiatrist​
    RHJ VA Medical Center​
    Charleston, South Carolina​

    Disclosures

    Disclosure: Mark S. George, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Brainsway; Magstim; Neurolief; Sooma
    Received grants for clinical research from: Brainsway; LivaNova; Neurolief

  • Scott H. Kollins, PhD

    Adjunct Professor​
    Department of Psychiatry and Behavioral Sciences​
    Duke University School of Medicine​
    Durham, North Carolina
    Chief Medical Officer​
    Holmusk, Inc.​

    Disclosures

    Disclosure: Scott H. Kollins, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Akili Interactive Labs, Inc.; Arbor Pharmaceuticals, Inc.; Ironshore Pharmaceuticals, Inc.; Otsuka Pharmaceutical Company, Inc.; Rhodes Pharmaceuticals, L.P.
    Received grants for clinical research from: BehaVR; Bose; KemPharm; Limbix; Neos; OnDosis; Rhodes Pharmaceuticals, L.P.; Tris Pharma, Inc.; Sana Health
    Owns stock, stock options, or bonds from: Akili Interactive Labs, Inc.

  • Rajnish ("Raj") Mago, MD

    Editor-in-Chief​
    Simple and Practical Mental Health​
    Clinical Professor of Psychiatry​
    SUNY Upstate Medical University, Syracuse, New York​
    Clinical Assistant Professor​
    University of Pennsylvania​
    Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Rajnish ("Raj") Mago, MD, has disclosed the following relevant financial relationships:
    Other: Royalties: Amazon.com

  • John Torous, MD, MBI

    Director
    Digital Psychiatry Division
    Department of Psychiatry
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts

    Disclosures

    Disclosure: John Torous, MD, MBI, has disclosed the following relevant financial relationships:
    Received grants for clinical research from: Otsuka Pharmaceutical Company, Ltd.

Editor

  • Clinton W. Wright, Pharm.D., BCPP

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Clinton W. Wright, Pharm.D., BCPP, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Nonpharmacologic and Digital Therapeutics: Psychiatry Updates

Authors: Hansa Bhargava, MD; Sanjay Gupta, MD; Geraldine Dawson, PhD; Mark S. George, MD; Scott H. Kollins, PhD; Rajnish ("Raj") Mago, MD; John Torous, MD, MBI; Faculty and Disclosures

CME / CE Released: 12/27/2021

Valid for credit through: 12/27/2022

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Beyond Pharmacotherapy: Therapeutic Brain Modulation in Psychiatric Disorders

Learn more about brain modulation for the treatment of psychiatric disorders.
Mark George, MD

Exploring Digital Solutions I: Pediatric Autism Spectrum Disorder

Learn more about digital solutions for pediatric ASD.
Geraldine Dawson, PhD

Exploring Digital Solutions II: Pediatric ADHD

Learn more about digital solutions for pediatric ADHD.
Scott Kollins, PhD

Technologies to Overcome Challenges for Patients to Access Psychiatric Care

Learn how to improve patient access to care with technology.
John Torous, MD, MBI

Pharmacogenomics and Precision Psychiatry

Learn about the use of pharmacogenomic testing for psychiatric treatment.
Rajnish (“Raj”) Mago, MD

Top Psychiatric Issues in Nonpharmacologic and Digital Therapeutics: Ask the Experts

Ask the faculty about nonpharmacologic and digital therapeutics used to treat psychiatric disorders.
Sanjay Gupta, MD
 

Assessment Survey

Before you begin, please take this brief survey.